-
CRISPR used to 'reprogram' cancer cells into healthy muscle in the labIn a new study, stopping skeletal-muscle cancer cells from making a specific protein forced them to turn into healthy muscle cells.
By Emily Cooke Published
cancer -
'Disappearing' Y chromosome in aging men may worsen bladder cancer, mouse study showsAs men get older, they can lose Y chromosomes in a portion of their cells. This could be helping certain cancers evade the immune system.
By Kiley Price Published
cancer -
AI predicts 5-year breast cancer risk better than standard tools — but we aren't sure how it worksArtificial intelligence models can use breast imaging data to pinpoint those at highest risk of getting breast cancer in the next five years, better than a standard approach.
By Carissa Wong Published
cancer -
Lung cancer pill drastically cuts risk of death after surgeryTaking the drug Tagrisso daily after surgery reduced non-small cell lung cancer patients' death risk by more than 50%.
By Jennifer Nalewicki Published
cancer -
Breast cancer screening should start at age 40, expert task force saysA task force of experts recommended that female patients be screened for breast cancer starting at age 40.
By Nicoletta Lanese Published
cancer -
New ultrasound device helps powerful chemo reach deadly brain cancers, human trial showsAn implanted ultrasound-emitting device helped chemotherapy drugs safely pass into the brains of cancer patients.
By Nicoletta Lanese Published
cancer -
Does it matter what time of day you get cancer treatment?The emerging field of "cancer chronotherapy" hints that it may be best to receive cancer treatment at a particular time of day.
By Nicoletta Lanese Published
cancer -
Black patients may need breast cancer screenings earlier than what many guidelines recommendA study suggests that Black patients might benefit from breast cancer screenings starting at age 42, rather than age 50.
By Nicoletta Lanese Published
cancer -
CRISPR-edited fat shrank tumors in mice. Someday, it could work in people, scientists say.Genetically modified fat can be transplanted into mice to shrink mouse and transplanted human tumors, but this novel cancer therapy still needs to be tested in human trials.
By Kamal Nahas Published
cancer
